Andrew D. Rackear - Net Worth and Insider Trading
Andrew D. Rackear Net Worth
The estimated net worth of Andrew D. Rackear is at least $4,481 dollars as of 2024-11-13. Andrew D. Rackear is the VP and General Counsel of Enzon Pharmaceuticals Inc and owns about 56,720 shares of Enzon Pharmaceuticals Inc (ENZN) stock worth over $4,481. Details can be seen in Andrew D. Rackear's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew D. Rackear has not made any transactions after 2012-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew D. Rackear
Andrew D. Rackear Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew D. Rackear owns 1 companies in total, including Enzon Pharmaceuticals Inc (ENZN) .
Click here to see the complete history of Andrew D. Rackear’s form 4 insider trades.
Insider Ownership Summary of Andrew D. Rackear
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENZN | Enzon Pharmaceuticals Inc | 2012-06-05 | VP and General Counsel |
Andrew D. Rackear Latest Holdings Summary
Andrew D. Rackear currently owns a total of 1 stock. Andrew D. Rackear owns 56,720 shares of Enzon Pharmaceuticals Inc (ENZN) as of June 5, 2012, with a value of $4,481.
Latest Holdings of Andrew D. Rackear
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENZN | Enzon Pharmaceuticals Inc | 2012-06-05 | 56,720 | 0.08 | 4,481 |
Holding Weightings of Andrew D. Rackear
Andrew D. Rackear Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew D. Rackear has made a total of 0 transactions in Enzon Pharmaceuticals Inc (ENZN) over the past 5 years. The most-recent trade in Enzon Pharmaceuticals Inc is the sale of 1,614 shares on June 5, 2012, which brought Andrew D. Rackear around $10,991.
Insider Trading History of Andrew D. Rackear
- 1
Andrew D. Rackear Trading Performance
Andrew D. Rackear Ownership Network
Ownership Network List of Andrew D. Rackear
Ownership Network Relation of Andrew D. Rackear
Andrew D. Rackear Owned Company Details
What does Enzon Pharmaceuticals Inc do?
Who are the key executives at Enzon Pharmaceuticals Inc?
Andrew D. Rackear is the VP and General Counsel of Enzon Pharmaceuticals Inc. Other key executives at Enzon Pharmaceuticals Inc include other: See Footnote 1 Family Fund Couchman , other: See explanation of responses Brian James Harper , and other: See explanation of responses Harper Asset Management Llc .
Enzon Pharmaceuticals Inc (ENZN) Insider Trades Summary
Over the past 18 months, Andrew D. Rackear made no insider transaction in Enzon Pharmaceuticals Inc (ENZN). Other recent insider transactions involving Enzon Pharmaceuticals Inc (ENZN) include a net purchase of 99,550 shares made by Randolph C Read ,
In summary, during the past 3 months, insiders sold 0 shares of Enzon Pharmaceuticals Inc (ENZN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzon Pharmaceuticals Inc (ENZN) were sold and 99,550 shares were bought by its insiders, resulting in a net purchase of 99,550 shares.
Enzon Pharmaceuticals Inc (ENZN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enzon Pharmaceuticals Inc Insider Transactions
Andrew D. Rackear Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew D. Rackear. You might contact Andrew D. Rackear via mailing address: 550 Hills Drive, 3rd Floor, Bedminster Nj 07921.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
